期刊文献+

APE1/Ref-1在卵巢癌中的功能研究进展 被引量:6

Research progress on function of APE1/Ref-1 in ovarian cancer
下载PDF
导出
摘要 脱嘌呤/脱氧嘧啶核酸内切酶1(APE1),又称为氧化还原因子1(Ref-1),是一种具有双功能酶活性的生物大分子,不仅具有核酸内切酶活性,能修复DNA的损伤,而且具有氧化还原功能,可通过调控多种转录因子的转录活性实现对基因表达的干预。研究发现APE1/Ref-1在卵巢癌中呈高表达状态,并与肿瘤的发生、发展及预后有关。APE1/Ref-1因其与卵巢癌的密切关系,而成为极具潜力的肿瘤基因治疗的新靶点。该文就APE1/Ref-1的定位、分子结构、生物学功能及其在卵巢癌发生发展研究方面的进展作了一系列的回顾与总结。 Apurinic/apuriminidic endonuclease 1( APE1),also named redox factor-1( Ref-1),is a biomacromolecule with bifunctional enzyme. APE1 not only has the endonuclease activity to repair DNA injury,but also has a redox function,which interferes the gene expression by regulating the activity of a variety of important transcription factors. Recent studies have suggested that the expression of APE1 / Ref-1 in ovarian cancer is high and it is correlated with tumor occurrence,progression and prognosis. Thus,APE1 / Ref-1 becomes a new target for cancer gene therapy because of its correlation with ovarian cancer. In this paper,we made a series of review and summary concerning the allocation,structure and functions of APE1 / Ref-1 as well as the research progress in ovarian cancer.
出处 《中国妇幼健康研究》 2016年第8期1027-1029,共3页 Chinese Journal of Woman and Child Health Research
基金 国家自然科学基金资助项目(编号:81402133)
关键词 脱嘌呤/脱氧嘧啶核酸内切酶 卵巢癌 氧化还原 核酸内切酶 apurinic/apuriminidic endonuclease 1(APE1) ovarian cancer redox endonuclease
  • 相关文献

参考文献25

  • 1Andres S N, Schellenberg M J, Wallace B D, et al. Recognition and repair of chemically heterogeneous structures at DNA ends [ J ]. Environ Mol Mutagen ,2015,56 ( 1 ) : 1-21.
  • 2Bakkenist C J, Czambel R K, Hershberger P A, et al. A quasi- quantitative dual multiplexed imunoblot method to simultaneously analyze ATM and H2AX Phosphorylation in human peripheral blood mononuclear cells [ J ]. Oncoscience, 2015,2 ( 5 ) : 542 -554.
  • 3Londero A P, Orsaria M, Tell G, et al. Expression and prognostic significance of APE1/Ref-1 and NPM1 proteins in high-grade ovarian serous cancer[ J]. Am J Clin Patho1,2014,141 (3) :404-414.
  • 4Wei X, Li Q, Li Y, et al. Prediction of survival prognosis of non- small cell lung cancer by APE1 through regulation of Epithelial- Mesenchymal transition [ J ]. Oncotarget, 2016,7 ( 19 ) : 28523-28539.
  • 5Thakur S, Dhiman M, Tell G, et al. A review on protein-protein interaction network of APEI/Ref-I and its associated biological functions[ J ]. Cell Biochem Funct, 2015,33 ( 3 ) : 101-112.
  • 6Li M, Wilson DM 3rd. Human apurinic/apyrimidinic endonuclease 1 [ J]. Antioxid Redox Signal ,2014,20(4) :678-707.
  • 7Tsutakawa S E, Lafrance-Vmlasse J, Tainer J A. The cutting edges in DNA repair, licensing, and fidelity : DNA and RNA repair nucleases sculpt DNA to measure twice, cut once [ J ]. DNA repair, 2014,19: 95 -107.
  • 8Schuermann D, Scheidegger S P, Weber A R, et al. 3CAPS - a structural AP-site analogue as a tool to investigate DNA base excision repair[ J]. Nucleic acids research,2016,44 (5) :2187-2198.
  • 9Abdel-Fatah T M, Arora A, Moseley P M, et al. DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers[J]. Oncotarget,2015,6(26) :21964-21978.
  • 10Thakur S, Sarkar B, Cholia R P, et al. APE1/Ref-I as an emerging therapeutic target for various human diseases: Phytochemical modulation of its functions [ J ]. Exp Mol Med,2014,46 : e106.

二级参考文献15

  • 1张颖,王建,王东,向德兵,辛晓燕.脱嘌呤/脱嘧啶核酸内切酶与卵巢上皮性癌耐药相关性研究[J].中国全科医学,2009,12(2):111-113. 被引量:4
  • 2Matsuo K,Eno ML,Im DD,et al.Chemotherapy time in-terval and development of platinum and taxane resistancein ovarian,fallopian,and peritoneal carcinomas[J].ArchGynecol Obstet,2010,281(2):325-328.
  • 3Tell G,Quadrifoglio F,Tiribelli C,et al.The many func-tions of APE1/Ref-1:not only a DNA repair enzyme[J].Antioxid Redox Signal,2009,11(3):601-620.
  • 4Heintz AP,Odicino F,Maisonneuve P,et al.Carcinoma ofthe ovary[J].Int J Gynaecol Obstet,2003,83(Suppl 1):135-166.
  • 5Armstrong DK.Relapsed ovarian cancer:challenges andmanagement strategies for a chronic disease[J].Oncolo-gist,2002,7(Suppl 5):20-28.
  • 6Huang HL,Fang LW,Lu SP,et al.DNA-damaging rea-gents induce apoptosis through reactive oxygen species-dependent Fas aggregation[J].Oncogene,2003,22(50):8168-8177.
  • 7Watenberg M,Ling FC,Muschen M,et al.Regulation ofthe multidrug resistance transporter P-glycoprotein in mul-ticellular tumor spheroids by hypoxia-inducible factor(HIF-1)and reactive oxygen species[J].FASEB J,2003,17(3):503-505.
  • 8Ziemann C,Burkle A,Kahl GF,et al.Reactive oxygenspecies participate in mdr1b mRNA and P-glycoproteinoverexpression in primary rat hepatocyte cultures[J].Cqrcinogenesis,1999,20(3):407-414.
  • 9Benhar M,Engelberg D,Levitzki A.ROS,stess-activatedkinases and stress signaling in cancer[J].Endocr RelatCancer,2007,14(4):1029-1038.
  • 10Safrit JT,Berek JS,Bonavida B.Sensitivity of drug-resist-ant human ovarian tumor cell lines to combined effects oftumor necrosis factor(TNF-alpha)and doxorubicin:fail-ure of the combination to modulate the MDR phenotype[J].Gynecol Oncol,1993,48(2):214-220.

同被引文献52

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部